FDA Drug Application (202270) for JANUMET XR by MERCK SHARP DOHME

Back to FDA Applications sponsored by MERCK SHARP DOHME

Application Number202270
Product Number001
FormTABLET, EXTENDED RELEASE;ORAL
Dosage500MG;EQ 50MG BASE
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameJANUMET XR
Active IngredientMETFORMIN HYDROCHLORIDE; SITAGLIPTIN PHOSPHATE

Active IngredientCount
List of drugs with Active Ingredient METFORMIN HYDROCHLORIDE32
List of drugs with Active Ingredient SITAGLIPTIN PHOSPHATE7


Back to FDA Applications sponsored by MERCK SHARP DOHME